Vaccines for Children
Pfizer testing for children as young as 6 months.
Pfizer and Moderna already applied for EUA for ages 12-15 y.o.
BioNTech (22UAy.DE) expects results by September from trials testing the COVID-19 vaccine that it and Pfizer (PFE.N) have developed in babies as young as six months old, German magazine Spiegel cited the company's CEO as saying.
www.reuters.com
Pfizer and Moderna got approval for their vaccines to go to 12-15 y.o. in Canada
Health Canada has authorized use of COVID-19 vaccine in adolescents aged 12 to 15 years under Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19
www.pfizer.ca
.8 to 1.0 Billion doses in 2021 to be produced. 3B doses in 2022.
Moderna can be refrigerated for a month, or kept in normal freezer for 7 months. Looking to make it 3 months just refrigerated.
Nations are saying the mRNA is the future of vaccines because of quick development.
Investments to increase supply globally, including doubling supply from Moderna’s ex- U.S. supply chain Supply also expected to benefit from shift to lower-dose product mix, including potential variant booster vaccines and pediatric primary vaccine doses Company increases its 2021 supply forecast
investors.modernatx.com
Moderna is socking cash into its manufacturing facilities and those of its contract manufacturing partners in Europe, in a move that could lift the biotech's COVID-19 vaccine supply to a whopping 3 billion doses next year.
www.fiercepharma.com
Moderna will more than double the size of its manufacturing site in Norwood, Massachusetts, to help reach its newly elevated COVID-19 vaccine supply forecasts. The latest renovations will boost the facility's vaccine production by 50%, the biotech said.
www.fiercepharma.com
Likely to produce 2.5B doses in 2021/
BioNTech and Pfizer (PFE.N) will boost manufacturing capacity of their COVID-19 vaccine to 2.5 billion doses by the end of 2021, BioNTech said on Tuesday, as it projected sales of nearly 10 billion euros ($11.7 billion) from the product this year.
www.reuters.com
AstraZeneca: Questioning of company's plan to get approval in the U.S. -- why bother? Fauci said probably would get approval, but not use.
As the weeks turn to months on AstraZeneca’s COVID-19 vaccine filing in the U.S., the big question is when? Its answer remains the same—soon. But with so many other shots available, why bother?
www.fiercepharma.com
Moderna working on boosters that target the newer variants.
Moderna posted sales of $1.94 billion in the first quarter mostly thanks to its COVID-19 vaccine, which generated $1.73 billion in sales during the period. Based on its latest supply agreements, Moderna also boosted its expected 2021 COVID-19 vaccine sales to $19.2 billion.
www.fiercepharma.com
Novavax is gearing up to produce over a billion doses.
ir.novavax.com
Novavax’s COVID-19 vaccine may be the next shot to receive emergency authorization in the U.S..
www.webmd.com
U.S. Pfizer plants now shipping to outside the U.S. (at least 10M to Mexico), which was banned in the previous administration.
By Carl O'Donnell (Reuters) - Pfizer Inc's shipment of COVID-19 vaccine to Mexico this week includes doses made in its U.S. plant, the first of what a...
whbl.com
U.S. Pfizer plants now shipping to outside the U.S. (to Canada, too), which was banned in the previous administration.
Pfizer Inc (PFE.N) will next week start supplying Canada with COVID-19 vaccine made in its U.S. plant, a senior official said on Friday, making it the second country to receive doses from the Kalamazoo, Michigan facility.
www.reuters.com
www.fox9.com
